Mass. Movers

Cubist agrees to acquire 2 drug makers

Lexington-based Cubist makes Cubicin.
Lexington-based Cubist makes Cubicin.

Cubist Pharmaceuticals Inc., best-known for its antibiotic Cubicin, will pay up to $1.6 billion to acquire two other drug makers in a bid to increase its line of antibiotics. The deal to buy Optimer Pharmaceuticals and Trius Therapeutics adds an antibacterial drug to its product portfolio and puts several other antibiotics in its pipeline for approval. The deals are expected to ultimately generate between $600 million and $1 billion in annual revenue, Cubist CEO Michael Bonney said.